MedPath

Study Comparing Bevacizumab + Temsirolimus vs. Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects

Phase 3
Completed
Conditions
Renal Cell Carcinoma
Interventions
Drug: Interferon-Alfa 9MU
Registration Number
NCT00631371
Lead Sponsor
Pfizer
Brief Summary

Primary objective: Comparison of independently assessed progression free survival (PFS) in subjects administered Bevacizumab + Temsirolimus vs. those administered Bevacizumab + Interferon-Alfa. Secondary objectives: safety, Investigator assessed PFS, objective response rate (independently assessed), and overall survival.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
791
Inclusion Criteria
  • Histologically and/or cytologically confirmed to have advanced renal cell carcinoma (RCC)
  • Majority component of conventional clear-cell type is mandatory
  • At least 1 measurable lesion (per RECIST)
Exclusion Criteria
  • Prior systemic treatment for RCC
  • Evidence of current or prior central nervous system (CNS) metastases
  • Cardiovascular disease
  • Pregnant or nursing women
  • Additional criteria applies

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
2Interferon-Alfa 9MUBevacizumab 10 mg/kg intravenous (IV) q8wks + Interferon-Alfa 9MU SC TIW
1TemsirolimusBevacizumab 10 mg/kg intravenous (IV) q8wks + Temsirolimus 25 mg IV weekly
1BevacizumabBevacizumab 10 mg/kg intravenous (IV) q8wks + Temsirolimus 25 mg IV weekly
2BevacizumabBevacizumab 10 mg/kg intravenous (IV) q8wks + Interferon-Alfa 9MU SC TIW
Primary Outcome Measures
NameTimeMethod
Progression-Free Survival (PFS): Independent-AssessmentBaseline until disease progression, initiation of new anticancer treatment, or death, assessed every 8 weeks (up to cut-off date: 19 April 2012)

PFS was defined as the interval from the date of randomization until the earlier date of progression or death. Progression was assessed by independent imaging reviewers using Response Evaluation Criteria in Solid Tumors (RECIST) criteria which is 20% increase in sum of longest diameter of target lesions from nadir (the lowest blood counts); measurable increase in non-target lesion; appearance of new lesions.

Secondary Outcome Measures
NameTimeMethod
Progression-Free Survival (PFS): Investigator-AssessmentBaseline until disease progression, initiation of new anticancer treatment, or death, assessed every 8 weeks (up to cut-off date: 19 April 2012)

PFS was defined as the interval from the date of randomization until the earlier date of progression or death. Progression was assessed by investigator imaging reviewers using RECIST criteria which is 20% increase in sum of longest diameter of target lesions from nadir (the lowest blood counts); measurable increase in non-target lesion; appearance of new lesions.

Percentage of Participants With Objective Response (Complete Response/Partial Response): Independent-AssessmentBaseline until disease progression, initiation of new anticancer treatment, or death, assessed every 8 weeks (up to cut-off date: 19 April 2012)

Percentage of participants with OR based assessment of confirmed complete response (CR) or confirmed partial response (PR) according to RECIST. Confirmed response were those that persisted on repeat imaging study at least 4 weeks after initial documentation of response. CR was defined as disappearance of all lesions (target and/or non target). PR were those with at least 30% decrease in sum of the longest dimensions of target lesions taking as a reference the baseline sum longest dimensions, with non target lesions not increased or absent.

Overall Survival (OS)Baseline until death due to any cause, assessed every 8 weeks (up to cut-off date: 19 April 2012)

OS was defined as the time from randomization to death due to any cause, censored at the last date known alive. Death was determined from adverse event data (where outcome was death) or from follow-up contact data (where the participant current status was death).

Trial Locations

Locations (169)

Uzsoki Utcai Korhaz

🇭🇺

Budapest, Hungary

Fundacion Arturo Lopez Perez

🇨🇱

Santiago, Chile

Pamela Youde Nethersole Eastern Hospital

🇭🇰

Chai Wan, Hong Kong

Klinika pneumologie a ftiziologie FNsP LFUK

🇸🇰

Bratislava, Slovakia

Nemocnica s poliklinikou Skalica

🇸🇰

Skalica, Slovakia

A.P Romodanov Itstitut nejrohirurhii

🇺🇦

Kiyv, Ukraine

Josa Andras Oktato Korhaz Nonprofit Kft.

🇭🇺

Nyiregyhaza, Hungary

Uniwersyteckie Centrum Kliniczne

🇵🇱

Gdansk, Poland

Veszprem Megyei Csolnoky Ferenc

🇭🇺

Veszprem, Hungary

Vedanta Institute of Medical Sciences

🇮🇳

Ahmedabad, Gujarat, India

The Cleveland Clinic

🇺🇸

Cleveland, Ohio, United States

Seattle Cancer Care Alliance

🇺🇸

Seattle, Washington, United States

Royal Adelaide Hospital

🇦🇺

Adelaide, South Australia, Australia

Jehangir Hospital

🇮🇳

Pune, Maharashtra, India

UCLA Medical Center

🇺🇸

Los Angeles, California, United States

University of Washington Medical Center

🇺🇸

Seattle, Washington, United States

Virginia Mason Medical Center

🇺🇸

Seattle, Washington, United States

Mater Adult Hospital

🇦🇺

South Brisbane, Queensland, Australia

Centro Goiano de Oncologia

🇧🇷

Goiania, GO, Brazil

ZNA Middelheim

🇧🇪

Antwerpen, Belgium

ISIS Clinica Especializado

🇦🇷

Santa Fe, Argentina

Cliniques Universitaires de Mont-Godinne UCL

🇧🇪

Mont-Godinne, Belgium

Instituto Nacional del Cancer

🇨🇱

Santiago, Region Metropolitana / Chile, Chile

Centro Medico San Roque

🇦🇷

San Miguel de Tucuman, Tucuman, Argentina

Centre médical Oncogard

🇫🇷

Nimes, France

Centre rené Gauducheau

🇫🇷

Saint-Herblain-Nantes, France

Ashford Cancer Center Research

🇦🇺

Kurralta Park, South Australia, Australia

Odette Cancer Centre, Sunnybrook Health Sciences Centre

🇨🇦

Toronto, Ontario, Canada

Fundação Pio XII - Hospital de Câncer de Barretos

🇧🇷

Barretos, Sao Paulo, Brazil

Instituto Clinico Oncologico del Sur

🇨🇱

Santiago, Chile

Fakultni nemocnice Olomouc

🇨🇿

Olomouc, Czech Republic

Krajska zdravotni, a.s.

🇨🇿

Usti nad Labem, Czech Republic

Centro Goiano de Oncologia - CGO

🇧🇷

Goiania, GO, Brazil

Oncologos del Occidente S.A

🇨🇴

Pereira, Risaralda, Colombia

CHU de Rouen

🇫🇷

Rouen Cedex, France

Universitair Ziekenhuis Gent

🇧🇪

Gent, Belgium

Jessa Ziekenhuis - campus Virga Jessa

🇧🇪

Hasselt, Belgium

Oblastni nemocnice Jicin a s

🇨🇿

Jicin, Ceska republika, Czech Republic

Hopital Foch

🇫🇷

Suresnes, France

Instituto Nacional do Cancer - INCA

🇧🇷

Rio de Janeiro, Brazil

Clinica de Oncologia de Porto Alegre - Sociedade Simples Ltda.

🇧🇷

Porto Alegre, RS, Brazil

Cancer Care SA

🇦🇺

Kurralta Park, Australia

Mater Private Hospital

🇦🇺

South Brisbane, Australia

Clinique Sainte Marguerite

🇫🇷

Hyères, France

Hospital Aranda de la Parra

🇲🇽

Leon, Guanajuato, Mexico

Universitaetsklinikum Hamburg Eppendorf

🇩🇪

Hamburg, Germany

Petz Aladar Megyei Oktato Korhaz

🇭🇺

Gyor, Hungary

Centrum Onkologii Ziemi Lubelskiej im. sw Jana z Dukli

🇵🇱

Lublin, Poland

Wojskowy Intsytut Medyczny, Zaklad Medycyny Nuklearnej CSK MON

🇵🇱

Warszawa, Poland

Tata Memorial Center

🇮🇳

Mumbai, Maharashtra, India

Yonsei University Health System-Severance Hospital

🇰🇷

Seoul, Korea, Republic of

Sezione di Oncologia Medica Centro di Ricerca Clinica

🇮🇹

Chieti, Italy

Masarykuv onkologicky ustav

🇨🇿

Brno, Czech Republic

Searoc Cancer Centre

🇮🇳

Jaipur, Rajasthan, India

Regional Cancer Centre

🇮🇳

Kerela, Trivandrum, India

Hopital Andre Mignot

🇫🇷

Le Chesnay, France

CHU de Poitiers

🇫🇷

Poitiers Cedex, France

Samsung Medical Center

🇰🇷

Seoul, Korea, Korea, Republic of

TU Muenchen, rechts der Isar

🇩🇪

Muenchen, Germany

Apollo Hospital

🇮🇳

Chennai, Tamil Nadu, India

Divisione di Urologia, Azienda Ospedaliera Policlinico Consorziale di Bari

🇮🇹

Bari, Italy

Farmacia del Comitato Etico Provinciale di Modena

🇮🇹

Modena, Italy

Klinikum Region Hannover, Krankenhaus Siloah

🇩🇪

Hannover, Germany

Queen Mary Hospital

🇭🇰

Hong Kong, Hong Kong

Unità Operativa di Oncologia, Azienda Ospedaliera Policlinico di Modena

🇮🇹

Modena, Italy

Spaarne Ziekenhuis

🇳🇱

Hoofddorp, Netherlands

University Malaya Medical Centre

🇲🇾

Kuala Lumpur, Malaysia

Wojskowy Intsytut Medyczny, Zaklad Diagnostyki Laboratoryjnej CSK MON

🇵🇱

Warszawa, Poland

GVI Oncology Trial Unit

🇿🇦

Kraaifontein, Cape Town, South Africa

Westridge Medical Centre

🇿🇦

Mayville, Durban, South Africa

Christie Hospital

🇬🇧

Withington, Manchester, United Kingdom

National Cancer Centre Singapore

🇸🇬

Singapore, Singapore

Fakultna Nemocnica s poliklinikou akad L Derera

🇸🇰

Bratislava, Slovakia

Hospital del mar de Barcelona

🇪🇸

Barcelona, Spain

City Pokrovskaya Hospital

🇷🇺

Saint-Petersburg, Russian Federation

China Medical University Hospital

🇨🇳

Taichung, Taiwan

Uchbobo-naukovyi likuvalnyi kompleks DDMU im. M.Gor'kogo

🇺🇦

Donetsk, Ukraine

"State Institution ""Institute for Occupational Health of the

🇺🇦

Kiev, Ukraine

University of the Witwatersrand Oncology

🇿🇦

Parktown, South Africa

Dr. Fourie & Voges

🇿🇦

Pretoria, South Africa

Nemocnica s poliklinikou Zilina

🇸🇰

Zilina, Slovakia

Tri-Service General Hospital

🇨🇳

Neihu, Tapei, Taiwan

Donetskyy Oblasyy protypukhlynnyy Tsenter

🇺🇦

Donetsk, Ukraine

Instituto Valenciano de Oncología

🇪🇸

Valencia, Spain

Veterans General Hospital-Taipei

🇨🇳

Taipei, ROC, Taiwan

Division of Oncology

🇨🇳

Tao Yuan, Taiwan

Langenhoven Drive Oncology Centre

🇿🇦

Port Elizabeth, South Africa

Hospital Universitario Marques de Valdecilla

🇪🇸

Santander, Cantabria, Spain

Hospital Sant Creu I Sant Pau

🇪🇸

Barcelona, Spain

Pretoria Urology Hospital

🇿🇦

Hatfield, Pretoria, South Africa

National Taiwan University Hospital

🇨🇳

Taipei TOC, Taiwan

Hospital de Madrid Norte-Sanchinarro

🇪🇸

Madrid, Spain

Clínica de Oncologia de Porto Alegre Sociedade Simples Ltda

🇧🇷

Porto Alegre, Rio Grande do Sul, Brazil

University of Leeds

🇬🇧

Leeds, North Yorkshire, United Kingdom

Medical Oncology Associates - SD

🇺🇸

San Diego, California, United States

Sharp Memorial Hospital Investigational Pharmacy

🇺🇸

San Diego, California, United States

California Pacific Medical Center

🇺🇸

San Francisco, California, United States

Pacific Hematology/Oncology Associates

🇺🇸

San Francisco, California, United States

San Francisco Oncology Associates

🇺🇸

San francisco, California, United States

Cohen & Hufford MD's INC

🇺🇸

San Francisco, California, United States

The Vanderbilt Clinic

🇺🇸

Nashville, Tennessee, United States

OU Medical Center

🇺🇸

Oklahoma City, Oklahoma, United States

OU Physician's Building

🇺🇸

Oklahoma City, Oklahoma, United States

University of Oklahoma

🇺🇸

Oklahoma City, Oklahoma, United States

IFO- Istituti Fisioterapici Ospitalieri

🇮🇹

Roma, Italy

Azienda Ospedaliera S. Maria

🇮🇹

Terni, Italy

Institut Gustave Roussy

🇫🇷

Villejuif Cedex, France

Instituto Nacional de Cancer - INCA

🇧🇷

Rio de Janeiro, RJ, Brazil

Instituto do Cancer do Estado de Sao Paulo Octavio Frias de Oliveira - ICESP

🇧🇷

Sao Paulo, SP, Brazil

City Hospital No.26

🇷🇺

Saint-Petersburg, Russian Federation

Sharp Rees-Stealy

🇺🇸

San Diego, California, United States

South County Hematology/Oncology

🇺🇸

Chula Vista, California, United States

Hematology Oncology Services of Arkansas

🇺🇸

Little Rock, Arkansas, United States

Cancer Center Oncology Medical Group

🇺🇸

La Mesa, California, United States

UCLA

🇺🇸

Los Angeles, California, United States

North County Oncology Medical Clinic

🇺🇸

Oceanside, California, United States

The Jones Clinic, PC

🇺🇸

Germantown, Tennessee, United States

Edmond Oncology Center

🇺🇸

Edmond, Oklahoma, United States

Centro Oncológico Rosario

🇦🇷

Rosario, Santa Fé, Argentina

ProCura - Centro Goiano de Pesquisa Clínica Ltda

🇧🇷

Goiania, GO, Brazil

Associaçao Hospital de Caridade Ijui

🇧🇷

Ijui, RS, Brazil

Irmandade da Santa Casa de Misericordia de Porto Alegre

🇧🇷

Porto Alegre, Brazil

Centre de Sante et de Services Sociaux de Rimouski - Neigette

🇨🇦

Rimouski, Quebec, Canada

Centre Jean Perrin

🇫🇷

Clermont-Ferrand, France

Vivantes Klinikum am Urban, Neztwerk fuer Gesundheit GmbH

🇩🇪

Berlin, Germany

Szegedi Tudomanyegyetem, Urologiai Klinika

🇭🇺

Szeged, Hungary

Struttura Complessa di Oncologia Medica Ospedale Santa Maria della Misericordia

🇮🇹

Perugia, Italy

Szpital Kliniczny Przemienienia Panskiego UM im. Karola Marcinkowskiego w Poznaniu

🇵🇱

Poznan, Poland

Hospital de San Joao

🇵🇹

Porto, Portugal

Leningrad Regional Oncology Dispensary

🇷🇺

Saint-Petersburg, Leningradskaya oblast, Russian Federation

Medical Radiology Research Center of the Minzdravsotsrazvitiya of Russia

🇷🇺

Obninsk, Kaluga region, Russian Federation

Republican Clinical Oncology Dispensary of Minzdrav of Tatarstan Republic

🇷🇺

Kazan, Russian Federation

Chair of Radiology and Radiotherapy

🇷🇺

Moscow, Russian Federation

N.N. Blokhin Russian Cancer Research Center, Department of Clinical Pharmacology and Chemotherapy

🇷🇺

Moscow, Russian Federation

N.N. Blokhin Russian Cancer Research Center, Department of Urology

🇷🇺

Moscow, Russian Federation

Moscow Scientific Research Oncology Institute P.A. Herzen

🇷🇺

Moscow, Russian Federation

Privolzhskiy District Medical Center of Federal Biomedical Agency

🇷🇺

Nizhni Novgorod, Russian Federation

Scientific research Institute of Oncology N.N. Petrov

🇷🇺

Pesochny, Saint-Petersburg, Russian Federation

Institute for Oncology and Radiology of Serbia

🇷🇸

Belgrade, Serbia

Clinical Center of Serbia

🇷🇸

Belgrade, Serbia

Fakultna Nemocnica s poliklinikou F D Roosevelta

🇸🇰

Banska Bystrica, Slovakia

Military Medical Academy

🇷🇸

Belgrade, Serbia

Oddelenie funkcnej diagnostiky

🇸🇰

Banska Bystrica, Slovakia

Klinika nuklearnej mediciny JLF UK a Martinskej fakultnej nemocnice

🇸🇰

Martin, Slovakia

Institut Catala Doncologia

🇪🇸

L'hospitalet de Llobregat, Barcelona, Spain

R.E.Kavetsky Institute of experimental pathology, oncology and radiobiology NAS of Ukraine,Laborator

🇺🇦

Kiev, Ukraine

Southampton General Hospital

🇬🇧

Southampton, Hampshire, United Kingdom

Hospital de Clinicas de Porto Alegre

🇧🇷

Porto Alegre, RS, Brazil

Instituto de Oncologia de Piracicaba S/S Ltda

🇧🇷

Piracicaba, SP, Brazil

Centrum Onkologii, Instytut im. M. Sklodowskiej-Curie

🇵🇱

Warszawa, Poland

Hospital de São João

🇵🇹

Porto, Portugal

Klinika tuberkulozy a plucnych chorob UK JLF a Martinskej fakultnej nemocince

🇸🇰

Martin, Slovakia

KK MED, s.r.o.

🇸🇰

Zilina, Slovakia

Universitet, kafedra onkologyy

🇺🇦

Chenivtsi, Ukraine

Donetske Obl. clinico-teritorial'ne medichne ob'yednannya

🇺🇦

Donetsk, Ukraine

Oblasnyy onkologychnyy dispanser, onkourologichne viddilennya, Ivano-Frankivskiy Derzhavniy Medichni

🇺🇦

Medychna vul., Ivano-Frankivsk, Ukraine

Orszagos Onkologiai Intezet

🇭🇺

Budapest, Hungary

Tata Memorial Centre

🇮🇳

Navi Mumbai, Maharashtra, India

Healthcare Global Enterprises Limited

🇮🇳

Bangalore, Karnataka, India

Lakeshore Hospital & Research Center Limited

🇮🇳

Kochi, Kerala, India

Wojskowy Instytut Medyczny, Pracownia Badan Cynnosciowych Ukladu Oddechowego, Klinika Chorob Wewnetr

🇵🇱

Warszawa, Poland

Klinica nuklcarncj mediciny

🇸🇰

Martin, Slovakia

MEDIVASA s.r.o.

🇸🇰

Zilina, Slovakia

Panorama Medical Centre

🇿🇦

Panorama, Cape Town, Western Cape, South Africa

Szpital Specjalistyczny im. L. Rydygiera Sp. z o.o.

🇵🇱

Krakow, Poland

Centrum Medyczne Ostrobramska NZOZ "Magodent"

🇵🇱

Warszawa, Poland

Jawaharlal Nehru Cancer Hospital, Department of Medical Oncology

🇮🇳

Bhopal, Madhya Pradesh, India

Guy's Hospital

🇬🇧

London, United Kingdom

Prince of Wales Hospital

🇭🇰

Hong Kong, Hong Kong

© Copyright 2025. All Rights Reserved by MedPath